MarketCap
Facebook
X
TelegramQuarterly report 2025-Q3
added 11-13-2025
VolitionRx Limited ROCE Ratio 2011-2026 | VNRX
Annual ROCE Ratio VolitionRx Limited
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 108.5 | 461.25 | 1234.18 | -159.87 | - | -92.03 | -118.09 | -119.15 | -54.76 | -151.78 | -826.75 | -412.24 | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 1234.18 | -826.75 | -11.89 |
Quarterly ROCE Ratio VolitionRx Limited
| 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -1036.27 | -1140.04 | -255.27 | 153.14 | -570.82 | -1330.43 | -1371.99 | -723.96 | -1005.42 | -562.92 | -761.48 | -551.03 | -586.74 | -340.98 | -164.58 | -77.39 | -105.03 | -96.98 | -106.81 | -95.67 | -120.34 | -117.36 | -114.62 | -77.31 | -113.94 | -125.91 | -134.26 | -104.79 | -143.7 | -145.98 | -142.95 | -107.01 | -123.44 | -100.96 | -80.44 | -42.25 | -91.34 | -124.0 | -143.33 | -121.35 | -600.3 | -1030.15 | -1282.08 | -1100.55 | -1236.53 | -893.56 | -762.14 | -423.24 | -527.88 | -496.55 | -454.37 | -312.51 | -312.51 | -207.87 | -96.16 | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 153.14 | -1371.99 | -413.5 |
ROCE Ratio of other stocks in the Diagnostics research industry
| Issuer | ROCE Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Anixa Biosciences
ANIX
|
-77.18 | $ 2.83 | -4.39 % | $ 91.8 K |  USA |
 |
Centogene N.V.
CNTG
|
-89.9 | - | -6.23 % | $ 30.6 M |  Germany |
 |
Agilent Technologies
A
|
25.0 | $ 116.37 | -1.49 % | $ 35.4 B | USA |
 |
Celcuity
CELC
|
-97.97 | $ 105.97 | -2.15 % | $ 4.18 B | USA |
|
Akumin
AKU
|
58.25 | - | -17.87 % | $ 25.9 M |  Canada |
 |
Oxford Immunotec Global PLC
OXFD
|
-2.26 | - | - | $ 562 M |  Britain |
 |
Charles River Laboratories International
CRL
|
0.8 | $ 173.71 | -2.76 % | $ 8.61 B | USA |
 |
Castle Biosciences
CSTL
|
1.9 | $ 27.4 | -2.11 % | $ 761 M | USA |
 |
Aspira Women's Health
AWH
|
-486.78 | - | -6.19 % | $ 10.5 M | USA |
 |
Accelerate Diagnostics
AXDX
|
62.7 | - | -61.36 % | $ 2.46 M | USA |
 |
Global Cord Blood Corporation
CO
|
12.48 | - | - | $ 399 M |  China |
 |
Fluidigm Corporation
FLDM
|
-18.87 | - | 1.08 % | $ 308 M | USA |
 |
Genetic Technologies Limited
GENE
|
-347.69 | - | - | $ 7.1 B |  Australia |
 |
Genetron Holdings Limited
GTH
|
-15.41 | - | 0.12 % | $ 80.1 M | China |
 |
PRA Health Sciences, Inc.
PRAH
|
9.75 | - | - | $ 10.7 B | USA |
|
Biodesix
BDSX
|
-41.6 | $ 15.93 | 1.14 % | $ 2.07 B | USA |
 |
Fulgent Genetics
FLGT
|
-6.52 | $ 13.83 | -2.61 % | $ 418 M | USA |
 |
Biocept
BIOC
|
-360.98 | - | -13.05 % | $ 7.29 M | USA |
 |
BioNano Genomics
BNGO
|
-293.94 | $ 1.11 | -3.07 % | $ 1.41 M | USA |
 |
Quest Diagnostics Incorporated
DGX
|
21.7 | $ 205.94 | -2.06 % | $ 22.9 B | USA |
 |
Danaher Corporation
DHR
|
8.93 | $ 202.02 | -1.88 % | $ 144 B | USA |
 |
Exact Sciences Corporation
EXAS
|
-8.59 | $ 103.3 | -0.05 % | $ 19.5 B | USA |
 |
Bioventus
BVS
|
-47.08 | $ 8.64 | -1.48 % | $ 541 M | USA |
 |
DarioHealth Corp.
DRIO
|
-66.97 | $ 10.5 | -2.33 % | $ 298 M |  Israel |
 |
DexCom
DXCM
|
33.2 | $ 73.05 | -1.0 % | $ 28.5 B | USA |
 |
QIAGEN N.V.
QGEN
|
1.9 | - | - | $ 10.6 B |  Niderland |
 |
Burning Rock Biotech Limited
BNR
|
-41.81 | $ 24.2 | -3.82 % | $ 258 M | China |
 |
CareDx, Inc
CDNA
|
-10.16 | $ 18.27 | -2.53 % | $ 974 M | USA |
 |
Chembio Diagnostics
CEMI
|
-132.81 | - | 0.22 % | $ 16.8 M | USA |
 |
ICON Public Limited Company
ICLR
|
4.69 | $ 105.46 | -2.6 % | $ 8.7 B |  Irlanda |
 |
IDEXX Laboratories
IDXX
|
61.76 | $ 642.76 | 0.95 % | $ 51.7 B | USA |
 |
Check-Cap Ltd.
CHEK
|
1809.55 | - | - | $ 9.42 M | Israel |
 |
Illumina
ILMN
|
-35.1 | $ 128.99 | -2.93 % | $ 20.5 B | USA |
 |
Guardant Health
GH
|
440.3 | $ 90.81 | -1.54 % | $ 11.4 B | USA |
 |
IQVIA Holdings
IQV
|
33.55 | $ 171.78 | -1.43 % | $ 29.5 B | USA |
 |
Brainsway Ltd.
BWAY
|
-17.75 | $ 22.69 | -4.22 % | $ 99.4 M | Israel |
 |
Laboratory Corporation of America Holdings
LH
|
16.06 | $ 280.06 | -2.17 % | $ 23.3 B | USA |
 |
Co-Diagnostics
CODX
|
-47.68 | - | - | $ 79.8 M | USA |
 |
Lantheus Holdings
LNTH
|
28.52 | $ 77.65 | 1.77 % | $ 5.24 B | USA |
 |
DermTech
DMTK
|
-181.44 | - | -11.32 % | $ 2.94 M | USA |
 |
Enzo Biochem
ENZ
|
-22.04 | - | -8.98 % | $ 14.8 K | USA |
 |
Mettler-Toledo International
MTD
|
35.8 | $ 1 309.79 | -1.0 % | $ 27 B |  Schweiz |
 |
Myriad Genetics
MYGN
|
-105.22 | $ 4.93 | -1.6 % | $ 457 M | USA |
 |
NeoGenomics
NEO
|
-9.11 | $ 9.13 | -3.89 % | $ 1.17 B | USA |
 |
Natera
NTRA
|
-76.66 | $ 200.13 | 0.2 % | $ 19.7 B | USA |
 |
Pacific Biosciences of California
PACB
|
-10354.48 | $ 1.51 | -7.1 % | $ 453 M | USA |
 |
Neogen Corporation
NEOG
|
-51.22 | $ 10.97 | -1.61 % | $ 2.38 B | USA |
 |
Heska Corporation
HSKA
|
-4.81 | - | - | $ 1.31 B | USA |
 |
HTG Molecular Diagnostics
HTGM
|
-219.45 | - | -20.0 % | $ 1.06 M | USA |
 |
Precipio
PRPO
|
-52.81 | $ 24.5 | -0.73 % | $ 31.8 M | USA |